Uncategorised – Page 10 – Market Industry Forecast News

Drug And Gene Delivery Devices Market Demand Rises with New Treatments

The global drug and gene delivery devices market size is expected to reach USD 1.22 billion by 2030, registering a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising investment by the market players to develop innovative drug delivery systems to cater to the demand by the patients as well as to increase the bioavailability at minimum quantity of active pharmaceutical ingredient is driving the market growth. Additionally, increasing focus on R&D of gene delivery systems owing to the high growth potential of gene therapy for the treatment of a wide range of diseases is expected to fuel the market growth in the future.

Drug delivery systems are in a constant evolution along with the changing preference by the patient. For instance, initially, hormone replacement therapy was widely prescribed in the form of pills, whereas, it is now available in the form of prefilled syringes, patches, vaginal rings, gel, and sprays. The principal purpose of development of different forms of delivery systems is to increase the ease of use. Factors such as aesthetics of the delivery systems, price, and amount of API are also considered while designing the drug delivery system.

Access the Drug And Gene Delivery Devices Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Inhalation, Transdermal), By Vector (Viral, Non-Viral), By Region, And Segment Forecasts, 2024 – 2030

Drug And Gene Delivery Devices Market Report Highlights

In 2023, the oral segment dominated the market and accounted for the largest revenue share of 52.7%, owing to its convenience and ease of administration.

The injectable segment is expected to witness the fastest CAGR of 11.0% during the forecast period, fueled by increasing prevalence of life-threatening diseases and advancement in injectable drug delivery devices.

In 2023, North America dominated the drug and gene delivery devices market with a revenue share of 54.0%, owing to the rising number of people suffering from chronic diseases.

The drug and gene delivery devices market in Asia Pacific is projected to witness growth during the forecast period. The growth can be attributed to the increasing prevalence of chronic diseases such as heart disease, diabetes and cancer owing to the changing lifestyle, increase in consumption of alcohols and cigarettes.

Key Drug And Gene Delivery Devices Company Insights

Some of the key companies in the drug and gene delivery devices market include, Uniqure N.V.; Shanghai Sunway Biotech Co., Ltd; Pfizer, Inc.; Johnson and Johnson.

UniQure NV develops adeno-associated virus (AAV) based gene therapies with the help of its gene technology platform and offers treatments to patients suffering with severe genetic disorders.

Epeius Biotechnologies Corporation develops anti-cancer agents that eliminate metastatic disease.

Order your free sample copy of “Drug And Gene Delivery Devices Market Report 2024 – 2030, published by Grand View Research

Key Drug And Gene Delivery Devices Companies:

The following are the leading companies in the drug and gene delivery devices market. These companies collectively hold the largest market share and dictate industry trends.

Uniqure N.V.,
SiBiono GeneTech Co.
Epeius Biotechnologies Corporation
Shanghai Sunway Biotech Co., Ltd
Pfizer, Inc.
F. Hoffmann-La Roche Ltd.
Johnson and Johnson
Novartis AG
Bayer AG
Becton, Dickinson and Company

About Grand View Research:

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit www.grandviewresearch.com

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Pico Projector Market Study Reveals Top Growth Drivers

The global pico projector market is expected to reach USD 19.20 billion by 2030, expanding at a CAGR of 21.2% from 2024 to 2030, according to a new study by Grand View Research, Inc. Smartphone proliferation coupled with high convenience when integrated with portable electronic devices is anticipated to elevate demand. Technological advancements have resulted in enhanced contrast ratio and high pixel quality. Portability and compatibility with Wi-Fi, WiMax, and 3G/4G technologies offered by these products is estimated to drive industry growth.

Pico projectors have the ability to project content from mobile and other electronic devices onto a wall, notebook, or portable projection screens. Strong economic growth coupled with rising consumer disposable income may catalyze adoption particularly in consumer electronics and automobiles. Increasing adoption of smart devices and the advent of Internet of Things (IoT) may catapult demand over the next few years. The industry is poised for growth due to expanding application areas and increasing demand for mobility across all sectors. Growing adoption of Bring Your Own Device (BYOD) policies in the corporate sector may also spur product demand.

Access the Pico Projector Market Size, Share & Trends Analysis Report By Technology, By Product (USB, Embedded, Media Player, Stand-alone), By Compatibility, By Application, By Region, And Segment Forecasts, 2024 – 2030

Pico Projector Market Report Highlights

The digital light processing segment accounted for the largest market revenue share at 49.9% in 2023. The segment growth is attributed to the advantages of DLP technology, which utilizes micro mirrors to control light and deliver images with color accuracy and brightness.

Standalone pico projectors accounted for the largest market share in 2023. These projectors allow users to connect with laptops, smartphones, or tablets.

The smartphones segment dominated with the largest market share in 2023. Integrating pico projectors with smartphones allows users to mirror their smartphone screens onto the projector, enabling presentations, video playback, and sharing multimedia content directly from their mobile devices, enhancing convenience and flexibility, making pico projectors an extension of smartphones for professional and personal use.

The consumer electronic segment dominated the market in 2023. The growing demand for portable and versatile entertainment solutions fuels the consumer electronics segment.

Key players in the industry include 3M, AAXA Technologies, Microvision Inc., Samsung Electronics Co. Ltd., Sony Corporation, STMicroelectronics N.V., Texas Instruments, and Coretronic Corporation. Industry participants strive to develop products with enhanced image quality, resolution and brightness. Prominent players also emphasize on developing new generation HD micro-display chips for enhancing product offering.

Key Pico Projector Company Insights

Some key companies in the pico projector market include AAXA TECHNOLOGIES INC.; Coretronic Corp.; and LG Electronics.

AAXA Technologies specializes in using advanced nano-LCoS (Liquid Crystal on Silicon) systems in some of its projectors. It offers a range of pico projectors, mini projectors, and LED projectors. AAXA claims to have made the world’s smallest 1080P projector. Some of its latest launches of pico projectors include SLC450, P6X, and L500.

Coretronic Corp. manufactures DLP projectors, interactive projection systems, image signal processing boxes, wearable display solutions, LCD backlight modules, high-lumen laser projectors, and automotive augmented reality heads-up displays. Its proprietary MCLA technology enhances the quality of its

projectors.

Order your free sample copy of “Pico Projector Market Report 2024 – 2030, published by Grand View Research

Key Pico Projector Companies:

The following are the leading companies in the pico projector market. These companies collectively hold the largest market share and dictate industry trends.

AAXA TECHNOLOGIES INC.
Acer Inc.
Coretronic Corp.
Koninklijke Philips N.V.
Lenovo
Miroir USA
Samsung
SYNDIANT
Texas Instruments Incorporated

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Sheet Molding and Bulk Molding Compound Market: Addressing Challenges in Supply Chain Management

The global sheet molding and bulk compound market size is expected to reach USD 5.90 billion by 2030, registering a CAGR of 6.39% from 2024 to 2030, according to a new report by Grand View Research, Inc.
Sheet molding compound (SMC) is widely used in transportation applications because of its excellent mechanics and lightweight nature. They have electrical insulation and are resistant to fire, corrosion, and stains. Traditional materials such as steel, iron, and aluminum are being supplanted by SMC and BMC due to their distinct perceived benefits. Automobile makers are probably going to rely less on steel and more on sheet molding compound (SMC) as the market for lightweight materials and solid compounds grows.

The report “Sheet Molding And Bulk Molding Compound Market Size, Share & Trends Analysis Report By Resin Type (Epoxy, Polyester), By Fiber Type (Glass Fiber, Carbon Fiber), By Application, By Region, And Segment Forecasts, 2024 – 2030” is available now to Grand View Research customers and can also be purchased directly

In addition to the intrinsic limits of metals and their rising costs, a number of firms are substituting metal for thermoset composites in high-performance applications. This is helping to drive the expansion of the sheet molding compound (SMC) market. Many firms now favor lightweight materials because of the direct correlation between fuel usage and the weight of the materials used in manufacturing.
The market offers a lot of room for expansion and innovation, especially in the area of environmentally friendly and sustainable composites development. Global attention to sustainability and minimizing environmental effect has led to an increase in demand for recyclable or renewable materials. Producers are allocating resources to R&D in order to develop recyclable composites and bio-based resins that preserve the performance attributes of conventional SMC and BMC. Moreover, the growing utilization of these materials in developing sectors including infrastructure construction and renewable energy presents fresh opportunities for market participants to flourish.

Sheet Molding And Bulk Molding Compound Market Report Highlights:
Based on fiber type, glass fiber held the market with the largest revenue share of 63.07% in 2023. Glass fiber is the most commonly used reinforcement material in SMC and BMC due to its excellent mechanical properties, cost-effectiveness, and versatility
Based on application, automotive & transportation held the market with the largest revenue share of 31.23% in 2023. The automotive & transportation sector is a major driver of market growth, as SMC and BMC materials are increasingly used for manufacturing lightweight and high-strength components, such as body panels, bumpers, and structural parts
North America holds a substantial share of the market, driven by robust demand from the automotive and aerospace industries. The U.S., in particular, is a major contributor, with its strong manufacturing base and technological innovation
Order your free sample copy of “Sheet Molding And Bulk Molding Compound Market Report 2024 – 2030, published by Grand View Research

Sheet Molding And Bulk Molding Compound Market Segmentation
Grand View Research has segmented the global sheet molding and bulk molding compound market based on resin type, fiber type, application, and region:
Sheet Molding And Bulk Molding Compound Resin Type Outlook (Volume, Kilotons; Revenue, USD Million, 2018 – 2030)
Epoxy
Polyester
Sheet Molding And Bulk Molding Compound Fiber Type Outlook (Volume, Kilotons; Revenue, USD Million, 2018 – 2030)
Glass Fiber
Carbon Fiber
Sheet Molding And Bulk Molding Compound Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 – 2030)
Automotive & Transportation
Aerospace
Electrical & Electronics
Building & Construction
Domestic Appliances
Others
Sheet Molding And Bulk Molding Compound Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 – 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Asia Pacific
China
India
Japan
Australia
South Korea
Central & South America
Brazil
Argentina
MEA
South Africa
Saudi Arabia

List of Key Players in the Sheet Molding And Bulk Molding Compound Market
IDI Composites International
National Composites
MENZOLIT
Polynt (Polynt-Reichhold)
Continental Structural Plastics Inc. (TEIJIN)
ZOLTEK (Toray Group)
Mitsui Chemicals
TORAY INTERNATIONAL
Core Molding Technologies
Devi Polymers Private Limited
Zhejiang Yueqing SMC & BMC Manufacture Factory
Huayuan Advanced Materials Co., Ltd.
Resonac Holdings Corporation

About Grand View Research:
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit www.grandviewresearch.com

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Automotive Lighting Market: Future Trends in Automotive Exterior Lighting

The global automotive lighting market size is estimated to reach USD 48.73 billion in 2030, growing at a CAGR of 5.95% from 2024 to 2030, according to a new report by Grand View Research, Inc. Strict government policies and rising safety concerns are likely to propel growth over the forecast period. In addition, growing consumer awareness concerning the significance of adaptive lighting including dynamic bend light and a glare-free high beam is also expected to have a positive impact on the exterior lighting market.

Increasing apprehensions about using energy-efficient methods coupled with rising consumer disposable income are expected to drive the industry. In addition, growing demand for vehicles and technological advancements in the automotive industry is expected to propel utilization. Attractive growth opportunities for new entrants are expected in the industry owing to the growing number of total vehicles purchased y-o-y across BRIC nations. However, there is a need for legislative authorities to collaborate with light sourcing technology suppliers to develop flexible design techniques.

THE Automotive LED market is estimated to demonstrate considerable growth at a CAGR of over 12.0% from 2015 to 2022. Halogen lights contributed to over 66.0% of overall industry revenue in 2014, followed by LED and xenon. It has gained prominence on account of easy availability, low purchasing costs, and low replacement costs. However, rising fuel prices are expected to pose a threat to the industry.

Access the Automotive Lighting Market Size, Share & Trends Analysis Report By Solution, By Technology (Halogen, Xenon/HID, LED), By Application, By Sales Channel, By Region, And Segment Forecasts, 2024 – 2030

Automotive Lighting Market Report Highlights

LED segment accounted for the largest market revenue share of 46.4% in 2023.

Front lighting/headlamps accounted for the largest market revenue share in 2023. The evolution of vehicle design and styling has elevated the importance of headlamp aesthetics.

Original Equipment Manufacturers (OEMs) accounted for the largest market revenue share in 2023. The increasing production and sales of vehicles globally directly contribute to OEMs’ demand for automotive lighting systems.

The passenger vehicle segment accounted for the largest market revenue share in 2023. The increasing consumer preference for aesthetically appealing and technologically advanced vehicles is boosting the demand for innovative lighting solutions in passenger vehicles.

North America automotive lighting market dominated the market in 2023.

Order your free sample copy of “Automotive Lighting Market Report 2024 – 2030, published by Grand View Research

Key Automotive Lighting Company Insights

Some of the key companies in the automotive lighting market include Sony Corporation, Samsung Electronics, Bosch Sensortec, Texas Instruments Incorporated., and STMicroelectronics. Organizations are focusing on increasing their customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions, and partnerships with other major companies.

Samsung Electronics offers a diverse range of products tailored to meet the automotive industry’s stringent requirements. Samsung’s portfolio includes LED headlights, taillights, interior lighting modules, and OLED displays, each designed to enhance vehicle safety, efficiency, and design aesthetics.

Texas Instruments (TI) offers a comprehensive portfolio of products and solutions designed to enhance safety, efficiency, and performance in automotive lighting applications. These include advanced LED driver ICs (Integrated Circuits) that enable precise control of LED brightness, color temperature, and dimming capabilities, which are crucial for achieving optimal visibility and energy efficiency in headlights, taillights, and interior lighting.

Key Automotive Lighting Companies:

The following are the leading companies in the automotive lighting market. These companies collectively hold the largest market share and dictate industry trends.

Sony Corporation
Samsung Electronics
Bosch Sensortec
Texas Instruments Incorporated.
STMicroelectronics
Omnivision Technologies
Analog Devices
Panasonic Corporation
Knowles Electronics
InvenSense

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Osteoporosis Drugs Market: Key Players Shaping the Future Landscape

The global osteoporosis drugs market size is expected to reach USD 18.80 billion by 2030 and is projected to grow at a CAGR of 3.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. An upsurge rise in the unhealthy lifestyle adoption has resulted in aggravation and increase in the prevalence of osteoporosis which is presumed to propel the osteoporosis drugs market during the forecast period.

In addition, growing number of patent expiries is fueling the high clinical urgency to use generic versions of the established drugs, which is presumed to fuel generic osteoporosis drugs market during the forecast period. The aforementioned factors cumulatively are slated to present the with high potential growth opportunities over the coming years.

Furthermore, rising number of initiatives to increase the awareness levels pertaining to osteoporosis care amongst the patients as well as the physicians is expected to widen the osteoporosis market growth potential during the forecast period. For instance, National Osteoporosis Foundation (NOF), a healthcare organization responsible for National Bone Health Alliance and Fracture Liaison Service (FLS) care coordination programs that focuses on elevating awareness levels as well as provides training to healthcare professionals

Access the Osteoporosis Drugs Market Size, Share & Trends Analysis Report By Drug Class (Branded, Generics), By Type (Bisphosphates, Parathyroid Hormone Therapy), By Distribution Channel, By Region, And Segment Forecasts, 2024 – 2030

Osteoporosis Drugs Market Report Highlights

Branded drugs held the dominant share of the product segment in 2023. The dominant share can be attributed to extensive utilization of bisphosphates, rank ligand inhibitors for the treatment of osteoporosis, possessing high efficacy

Generics are expected to witness at a lucrative CAGR owing to consistent patent expiries over the coming years as well as high clinical urgency for inexpensive medication in the emerging economies

In 2023, North America accounted for the largest share in the global osteoporosis drugs market owing to the presence of established companies extensively involved in the commercialization of branded therapeutics

Asia Pacific is anticipated to grow at an exponential CAGR as a consequence of favorable government initiatives promoting information pertaining to osteoporosis care

The key participants are employing sustainability strategies promoting the adoption of osteoporosis therapeutics to gain competitive advantage. For instance, Actavis Inc. announced to acquire Warner Chilcott PLC in order to widen their product portfolio

Order your free sample copy of “Osteoporosis Drugs Market Report 2024 – 2030, published by Grand View Research

Key Osteoporosis Drugs Company Insights

Some key companies in the osteoporosis drugs market include Amgen Inc; Eli Lilly and Company; Merck & Co., Inc.; Novartis AG; GlaxoSmithKline plc; Pfizer Inc.; Radius Health Inc.; UCB S. A.; Teva Pharmaceuticals Industries Ltd. in the market are focusing on the development of osteoporosis drugs to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives.

Amgen Inc. develops, manufactures, and markets innovative human medicines to treat patients suffering from serious diseases. It develops novel medicine for treating cardiovascular conditions, oncology/hematology, inflammation, bone health, neurological disorders, and nephrology conditions.

Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company uses innovative science and digital technologies to create transformative treatments in areas of great medical need. Novartis offers patent-protected prescription medicines, generic pharmaceuticals, and biosimilars.

Key Osteoporosis Drugs Companies:

The following are the leading companies in the osteoporosis drugs market. These companies collectively hold the largest market share and dictate industry trends.

Amgen Inc.
Eli Lilly and Company
Merck & Co., Inc.
Novartis International AG
Pfizer Inc.
GlaxoSmithKline plc
Radius Health, Inc.
UCB S.A.
Teva Pharmaceutical Industries Ltd.
Roche Holding AG

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

CIS Insulin Market: The Impact of COVID-19 on Diabetes Care

The CIS insulin market size is expected to reach USD 4.67 billion by 2030, registering a CAGR of 5.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The presence of an extensive pipeline portfolio of products exhibiting higher efficacies and their subsequent commercialization over the next six years is expected to serve this market as a high impact rendering driver. The introduction of government initiatives aimed at improving the affordability of insulin via price reduction, such as the collaboration between the government of Ukraine and Indar to reduce the price of insulin by 20% in 2013 is expected to have positive influence on demand. Some of the other drivers of this market include increasing attempts made by manufacturers to capitalize on the untapped opportunities by opening new manufacturing units to improve the supply of insulin and growing incidence rates of type II diabetes are some of the factors expected to fuel future market growth.

Access the CIS Insulin Market Size, Share & Trends Analysis Report By Product, By Type (Human Insulin, Insulin Analog), By Application (Type 1 Diabetes), By Distribution Channel, By Region, And Segment Forecasts, 2024 – 2030

CIS Insulin Market Report Highlights

Poland CIS Insulin market held a substantial market share of 10.3% in 2023 due to various factors influencing market growth, including drivers, constraints, opportunities, and threats

Long-acting Insulin dominated the market and accounted for a share of 52.7% in 2023. Long-acting insulins mimic natural insulin with a slower onset of action and are mainly utilized as basal insulins.

Type 1 Diabetes dominated the market and accounted for a share of 79.6% in 2023. Type 1 diabetes primarily affects children, teenagers, and some adults. Type 2 Diabetes is expected to register the fastest CAGR of 11.6% during the forecast period, driven by the increasing prevalence of the condition in the CIS region.

Insulin analog led the market with the largest revenue share of 89.0% in 2023. Insulin analogs are a form of engineered insulin that starts working quickly and has an instant impact on the body’s functions.

Key CIS Insulin Company Insights

Leading insulin manufacturers are adopting strategies such as new product launches, partnerships, and mergers to increase market share. The arrival of biosimilar insulin has created opportunities for new players. Governments in the CIS region are providing support to local producers, encouraging multinational companies to set up production units. Investments in R&D are also driving innovation in insulin drugs and devices.

Order your free sample copy of “CIS Insulin Market Report 2024 – 2030, published by Grand View Research

Some of the key companies in the CIS Insulin market include

Novo Nordisk A/S focuses on developing, manufacturing, and selling pharmaceutical products. The company specializes in providing diabetes care, including insulin delivery systems and various other diabetes products. Novo Nordisk is also active in fields such as managing haemostasis, treating growth disorders, and providing hormone replacement therapy.

Eli Lilly and Company, a pharmaceutical company transforms scientific research into treatments to improve the lives of individuals globally. By utilizing biotechnology, chemistry, and genetic medicine, company is pushing the boundaries of science to address major global health issues.

Key CIS Insulin Companies:
Eli Lilly and Company
Sanofi S.A.
Boehringer Ingelheim International GmbH
Oramed Pharmaceuticals Inc.
Novo Nordisk A/S
Merck & Co., Inc.
Bristol-Myers Squibb Company
Novartis AG

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Biotech Flavor Market: Addressing Challenges in Flavor Production

The global biotech flavor market size is expected to reach USD 2.45 billion by 2030, expanding at a CAGR of 8.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing awareness regarding nutritional benefits such as stimulation of appetite and content of citric acid to boost immune and rising health consciousness are expected to drive the market in the next few years.

Growing penetration of natural flavoring due to advancement in various types of beverages has been driving the demand for the global market. Beverages infused with biotech flavors help in boosting energy level, metabolism, and other bodily functions. Flavors such as lemon and cucumber help in stimulating liver functions and strengthening veins. Growing trend of convergence between biotech and nutraceuticals driven by increasing application of ingredients claims to have various health benefits. For instance, Robertet introduced Xtreme Flavors with high impact, true fruit, authentic, and natural flavoring that can be infused in various beverage preparations. Some of the flavors include plum and plum sugar, pear, watermelon, and apple.

Access the Biotech Flavor Market Size, Share & Trends Analysis Report By Type (Vanilla, Fruity Flavor, Others), By Form (Liquid, Powder, Paste), By Application, By Region, And Segment Forecasts, 2024 – 2030

The powder form held the largest market share and generated a revenue of USD 17.1 billion in 2018. This segment consists of energy drinks powder, yogurt powder, butter powder, and others with features that are applicable in maintaining health. The liquid form is expected to expand at a CAGR of 7.4% over the forecast period. Growing awareness and popularity of liquid form due to its wide usage in beverages such as fruits and vegetables juices, energy drinks, and sodas with the respective taste preference is the key factor driving the segment demand.

Vanilla flavor accounted for the largest market share with a revenue of USD 17.8 in 2018. This flavoring is mostly used in food products due to its benefits such as powerful antioxidant, antibacterial, anti-inflammatory, and cholesterol stabilizers. Fruity flavor is expected to register a CAGR of 7.3% in the forecast period due to increased application in the form of jams and growing research and development expenditure in the respective market. Consumers are demanding healthier options for food spreads and fillings, which, in turn, has driven the demand for fruity flavors. Major market players have been significantly carrying out research and development to make these products available according to the needs of consumers. For instance, IFF Inc. derives natural ingredients from flowers, fruits, and botanical products with the help of specialized drying technology by eliminating water with best taste, nutrition, and color matrix intact in juice drinks, carbonated beverages, candy chewing gum, yogurt, ice cream, and cheese.

North America was the largest regional market with a revenue of USD 14.2 billion in 2018. The region is expected to maintain its lead over the forecast period. Increasing preference for healthy ready to eat and drink products in U.S. is expected to drive the companies to develop more of biotech flavor infused consumables. Growing consumption of packaged food is another driver for the market growth in the region. Key players in the global market include Givaudan; Firmenich SA; IFF Inc.; Symrise AG; Wild Flavors; Takasago International Corporation; Mane Flavors; Frutarom; Sensient Technology Ltd.; and Roberetet.

Biotech Flavor Market Report Highlights

· By type, fruity flavor is expected to register a CAGR of 9.0% from 2024 to 2030

· The powder segment accounted for the largest market revenue share in 2023.

· North America dominated the biotech flavor market with a revenue share of 39.6% in 2023.

· Asia Pacific Biotech Flavors market is anticipated to witness significant growth in the biotech flavor market.

· The biotech flavor market is highly competitive in nature due to presence of the main players including Givaudan

· Various manufacturers are concentrating on new product launches and capacity expansion to estimate existing and future demand patterns from upcoming product segments.

Order your free sample copy of “Biotech Flavor Market Report 2024 – 2030, published by Grand View Research

Key Biotech Flavor Company Insights

Some of the key companies in the biotech flavor market include Givaudan SA, Firmenich SA, Symrise AG, International Flavors & Fragrances Inc. (IFF), Takasago International Corporation, Sensient Technologies Corporation, Kerry Group plc, Bell Flavors & Fragrances Inc., and Flavorchem Corporation. Vendors in the market are focusing on increasing customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions, and partnerships with other major companies.

Firmenich SA offers high-quality fragrances, flavor components, and oral care items. The company’s offerings in the biotech flavor space include a sequence of innovative ingredients designed to provide customers with essential nutrients, catering to the growing interest in natural, sustainable, and clean-label products.

Givaudan SA’s biotech flavor offerings are built upon its molecular biology, fermentation technology, and expertise in extracting natural ingredients. The company specializes in developing flavors through microbial fermentation and enzymatic transformation, allowing the production of authentic and sustainable flavor profiles. These biotech flavor are designed to meet stringent regulatory standards and consumer preferences for clean-label products that are natural, transparent, and free from synthetic additives.

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Hydrogel-based Drug Delivery System Market Key Insights: Navigating Emerging Trends

The global hydrogel-based drug delivery system market size is anticipated to reach USD 11.77 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2024 to 2030. Hydrogels help in achieving spatial and temporal control over the release of the incorporated drug. Therefore, the surging demand for controlled releases drug delivery system across many therapeutic areas is a key factor expected to contribute to market growth during the forecast period.

Hydrogel-based drug delivery systems deliver the therapeutic drug directly at the target site and in a sustained manner. This can leverage beneficial outcomes such as improved efficacy, reduced side effects, and decreased dosage for patients and formulators. Hydrogel-based drug delivery systems are appealing and have been used in many branches of medicine such as oncology, pain management, immunology, cardiology, and wound management.

Access the Hydrogel-based Drug Delivery System Market Size, Share & Trends Analysis Report By Polymer Origin (Natural, Synthetic, Hybrid), By Delivery Route, By Region, And Segment Forecast, 2024 – 2030

The unique physical properties of hydrogel attract their interest in use for drug delivery applications. The porosity and drug loading capacity of hydrogels can be adjusted by modifying the density of cross-linking. This helps them to protect liable large drug molecules from degradation increasing the half-life. Many research studies have been carried out to examining the delivery of insulin orally using hydrogel systems. As patient compliance issues are frequently reported with injectable insulins such innovation is expected to be a disruptive technology in the diabetes care market.

There are numerous clinical studies underway specific to hydrogel-based drug delivery systems and various hydrogel technologies have already received regulatory approval for biomedical application. However, the technological challenges including the absence of defined regulatory guidelines, chemistry, complex manufacturing and control paraments, and practical adaptability are major roadblocks in the successful implementation in drug delivery use. For instance, the fabrication of hydrogel is complex and varies significantly depending upon the hydrogel systems.

Hydrogel-based Drug Delivery System Market Report Highlights

Based on polymer origin, the synthetic segment held the largest proportion of market share in 2023

The hybrid segment is expected to witness the fastest growth rate over the forecast period owing to the development of stimuli-responsive hydrogel technology

The synthetic segment is anticipated to grow fast over the forecast period compared to natural hydrogels due to their high drug loading capacity and improved mechanical strength

Based on delivery route, the ocular segment accounted for the largest revenue share in 2023

The subcutaneous segment is expected to grow at a healthy rate over the forecast period owing to the increasing number of clinical and pre-clinical studies carried out

North America holds the largest revenue share in this market due to the presence of key companies in the region doing R&D on specific hydrogel-based drug delivery systems

In Asia Pacific, the market is expected to grow at the fastest rate over the forecast period due to large patient base, improving healthcare infrastructure, and surging demand for modern therapies

Order your free sample copy of “Hydrogel-based Drug Delivery System Market Report 2024 – 2030, published by Grand View Research

Key Hydrogel-based Drug Based Delivery System Company Insights

Some key companies in the market include GALDERMA; Blairex Laboratories, Inc.; Johnson & Johnson; Bausch + Lomb; Medtronic; and Ocular Therapeutix, Inc. Vendors in the market are focusing on increasing their customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions, and partnerships with other emerging and prominent industry participants.

Ocular Therapeutix, Inc., is a biopharmaceutical company that specializes in creating, advancing, and marketing new treatments for eye disorders. It employs its own bioresorbable hydrogel-based formulation technology, ELUTYX. The company has manufacturing facilities in Massachusetts.

Blairex Laboratories, Inc., a global pharmaceutical company, delivers products related to the consumer and pharmaceutical industry. Some of the company’s major offerings are sterile saline solutions and contact lens care.

Key Hydrogel-based Drug Delivery System Companies:

The following are the leading companies in the hydrogel-based drug delivery system market. These companies collectively hold the largest market share and dictate industry trends.

GALDERMA
Blairex Laboratories, Inc
Johnson & Johnson
Bausch + Lomb.
Medtronic
Ocular Therapeutix, Inc.
Ferring B.V.
Endo, Inc.
Tolmar Inc

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Military Wearable Medical Devices Market Key Insights: Navigating Emerging Trends

The global military wearable medical devices market size is expected to reach USD 38.77 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 26.3% from 2024 to 2030. The growth of the market is attributed to the improvement in the overall performance of military soldiers with the help of innovative technology and the rising demand for lightweight military devices.

The Covid-19 pandemic has transformed the market for military wearable medical devices because wearable technologies could monitor, detect, and prevent the spread of the virus. The Covid-19 virus has indirectly increased the demand for wearable medical devices. According to the WHO guidelines, viral infection mainly spreads through the eyes, nose, and mouth and it is difficult to identify the virus during the initial days of contract. Hence, with the innovative technology, the individual can regularly check and monitor their body temperature, oxygen level, heart rate, and body performance so that if they found any negative result, then they can immediately take precautions and treatment.

Access the Military Wearable Medical Devices Market Size, Share & Trends Analysis Report By Application (Heart, Performance Monitor), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2024 – 2030

As soldiers have to train and work in a rough and harsh environment, the wearable device they are carrying must be lightweight and must provide full information of the soldier’s health and performance. Many market players are developing and introducing such wearable devices, which can bear the toughest environment of the battlefield. With the help of the device, armed forces can track and monitor the sleep of every individual, circadian stability, and all physical activity so that they can make necessary changes for better results as per the data.

As per the soldier modernization program, the military has decided to opt for lightweight wearable devices as soldiers already have to carry heavy stuff with them and such devices can increase the speed of the movement. The devices should be easy to carry and made of the toughest material to adapt to the environment. These devices should result in the betterment of the overall performance of the individuals.

Military Wearable Medical Devices Market Highlights

By application, the heart monitor segment held the largest revenue share in 2023 as the system directly detects any uncertain change in the health of an individual, and the patient can be treated as early as possible

North America led the market in 2023 and is expected to maintain its lead over the forecast period owing to technological advancements and increasing R&D investment in military devices

Asia Pacific is expected to witness the fastest growth over the forecast period due to the rising cardiovascular events in the region and rising healthcare spending

The industry is highly competitive with players who are developing advanced medical devices for the soldiers that can be used in war zones or in extreme environments

Order your free sample copy of “Military Wearable Medical Devices Market Report 2024 – 2030, published by Grand View Research

Key Military Wearable Medical Devices Company Insights

Some key companies in the market include Samsung, Bittium, Garmin, Apple Inc., Fitbit, and GOQii. Companies are focusing on longer battery life, connectivity, and accurate readings in the devices.

Garmin has been deploying products in segments such as automotive, marine, aviation, sports & outdoor with a focus on rugged use and long battery life providing a wide range of services through their devices such asMulti-GNSS Support, ABC sensors, trackback routing, geocaching, point-to-point navigation, compass, GPS compass.

Apple Inc. monitors heart rates, fall detection, blood oxygen level, and AFib history with the help of an electrical heart sensor in their product.

Key Military Wearable Medical Devices Companies:

The following are the leading companies in the military wearable medical devices market. These companies collectively hold the largest market share and dictate industry trends.

Bittium
Polar Electro
Oura
Garmin
NeuroMetrix
GOQii
Apple Inc.
Samsung
Fitbit
Zephyr Technology Corporation
Camntec

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com

Buttock Augmentation Market Key Insights: Navigating Emerging Trends

The global buttock augmentation market size is anticipated to reach USD 11.72 billion by 2030, according to the new report of Grand View Research, Inc. The market is expected to expand at a CAGR of 21.5% from 2024 to 2030. Buttock augmentation also called gluteal augmentation is a technique used to contour, size, and enhance the appearance. A buttock lift is reported to improve the tone of the underlying tissue and is mainly done by using implants, fat grafting, or sometimes a combination of the two.

Factors like rising technological advancement in aesthetics, rising disposable income, increasing aesthetic consciousness and the high success rate of augmentation procedures are propelling the market growth. According to the International Society of Aesthetic Plastic Surgery, around 5, 34,345 butt augmentation and lift procedures were carried out globally in 2019. Buttock augmentation accounts for 4.7% of total surgical procedures globally.

Access the Buttock Augmentation Market Size, Share & Trends Analysis Report By Procedure (Buttock Implants, Buttock Injections), By End-use (Hospitals, Aesthetic Clinics), By Region, And Segment Forecasts, 2024 – 2030

Growing social media influence, high consciousness towards aesthetic appearance, and its association with self-confidence and self-image by an individual are some of the reasons for market growth. In the light of COVID-19, the market was hampered as patient appointments for surgical treatments were temporarily suspended. However, since the government in many countries has allowed resuming elective surgical procedures, clinics have also started buttock lift and grafting procedures again. Moreover, according to the BBC network, inquiries and appointments for many surgical and non-surgical cosmetic treatments have seen a surge following the pandemic and are thus expected to propel market growth.

Buttock Augmentation Market Report Highlights

By procedure, the buttock implant procedure segment held the largest revenue share in 2023 as techniques like fat grafting and butt lift are more in demand and has faster post-operative healing

Based on implant type, the fat grafting segment accounted for the largest revenue share in 2023 as this procedure is less complicated, takes less operative time, and has more success rate

In North America, the market accounted for the largest revenue share in 2023 as the region has a high awareness of such procedure and there is high availability of aesthetic professionals

In Asia Pacific, the market is expected to grow significantly in the forecast period owing to technological advancements and an increase in patients opting for procedures to improve aesthetic appearances

Order your free sample copy of “Buttock Augmentation Market Report 2024 – 2030, published by Grand View Research

Key Buttock Augmentation Company Insights

Some of the companies key companies in global buttock augmentation market are Abbvie (AllerganAesthetics), GC Aesthetics, Sebbin, and other. To develop a competitive edge over others, the key companies have embraced strategies such as innovation.

Allergan Aesthetics, a subsidiary of the global pharmaceutical organization AbbiVie, develops, manufactures, and distributes offerings related to body contouring, facial injectables, skin care, and plastics. The company also invests heavily in research and development activities to deliver innovation-backed products. It is headquartered in Irvine, California, and has several manufacturing sites across multiple locations around the world.

GC Aesthetics, one of the prominent players in aesthetic enhancements and pre & post-surgery solutions, primarily delivers offerings related to breast enhancements, face implants, body implants, and Remote Valve Tissue Expanders (RVTEs).

Key Buttock Augmentation Companies:

The following are the leading companies in the buttock augmentation market. These companies collectively hold the largest market share and dictate industry trends.

Abbvie. (AllerganAesthetics)
Dermax Co. Ltd.
GC Aesthetics
Implantech
Sientra Inc.
Sebbin
Merz Pharma
Alpha Aesthetics
Hanson Medical Inc.
GALDERMA 2024
CGBio

About Grand View Research:

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058
Email: sales@grandviewresearch.com